Clinical Trial Update: A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating the safety and feasibility of adding FOLFIRINOX chemotherapy to neoadjuvant radiation for gastric and gastroesophageal junction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• FOLFIRINOX regimen (folinic acid, fluorouracil, irinotecan, oxaliplatin) (FOLFIRINOX)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: GastroEsophageal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-05-07